Updated at 7 PM with a detailed comment at the bottom from C. Michael Minder of Johns Hopkins– In a New York Times Op-Ed piece on Monday, Eric Topol comments on last week’s announcement by the FDA that it was changing the label for statins. Topol focuses on the new warning that statins raise the risk…
Rita Redberg and Roger Blumenthal Clash Over Statins for Primary Prevention in the Wall Street Journal
January 23, 2012 by 8 Comments
The debate over whether statins should be used for primary prevention moved to the Wall Street Journal with opposing perspectives from cardiologists Roger Blumenthal and Rita Redberg. Blumenthal argues that “there is a mountain of high-quality scientific evidence” to support the use of statins in people without known heart disease but “demonstrated to be at high…
Study Examines Changes in Resting Heart Rate Over Time
December 21, 2011 by 1 Comment
Although resting heart rate (RHR) has been long known to be associated with cardiovascular risk, change in RHR over time has not been well studied. A new paper from Norway published in JAMA demonstrates that an increase in RHR over 10 years helps predict the risk of all-cause and ischemic heart disease (IHD) death. Javaid Nauman…
Recent Comments